Institutional Ownership
Lenz Therapeutics Inc
CUSIP 52635N103COMLENZQ1 2026
13D / 13G Filings
25
Schedule 13D/13G on record
Beneficial Filers
12
Distinct reporting persons
Largest Stake
16.6%
Max % of class reported
Institutional Holders
137
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
25 filings · latest Feb 17, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 17, 2026 | Ridgeback Capital Investments L.P. | 13G/A | — | — | SEC |
| 2 | Feb 5, 2026 | Fmr LLC | 13G/A | 11.8% | 3.70M | SEC |
| 3 | Jan 21, 2026 | Blackrock, Inc. | 13G/A | 4.9% | 1.54M | SEC |
| 4 | Nov 14, 2025 | Paradigm Biocapital Advisors LP | 13G/A | 3.8% | 9.23B | SEC |
| 5 | Nov 14, 2025 | Point72 Asset Management, L.P. | 13G/A | 4.8% | 1.36M | SEC |
| 6 | Nov 10, 2025 | Versant Venture Capital Vi, L.P. | 13D/A | 3.4% | — | SEC |
| 7 | Nov 7, 2025 | Ra Capital Management, L.P. | 13D/A | 13.6% | — | SEC |
| 8 | Nov 7, 2025 | Fmr LLC | 13G | 15.0% | 4.28M | SEC |
| 9 | Oct 17, 2025 | Blackrock, Inc. | 13G | 5.1% | 1.44M | SEC |
| 10 | Sep 22, 2025 | Versant Venture Capital Vi, L.P. | 13D/A | 4.1% | — | SEC |
15 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Lenz Therapeutics Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Ra Capital Management, L.P. | 4.18M | $38.24M |
| 2 | Alpha Wave Global, LP | 3.61M | $33.05M |
| 3 | Fmr LLC | 3.60M | $32.92M |
| 4 | Versant Venture Management, LLC | 2.66M | $24.31M |
| 5 | Blackrock, Inc. | 1.98M | $18.09M |
| 6 | Squarepoint Ops LLC | 1.51M | $13.78M |
| 7 | Aberdeen Group PLC | 1.16M | $10.58M |
| 8 | Franklin Resources Inc | 1.10M | $10.07M |
| 9 | 72 Investment Holdings, LLC | 1.02M | $9.31M |
| 10 | Millennium Management LLC | 869.3K | $7.95M |